Search results
Timing of Chemo Could Be Key to Pancreatic Cancer Outcomes
Fox Bangor· 1 day agoGiving people with pancreatic cancer chemotherapy both before and after a tumor-removing surgery...
New Biomarker Detects Chemotherapy-Related Neurotoxicity
Medscape· 10 hours agoLevels of neurofilament light chain may be a biomarker of chemotherapy-induced peripheral...
Top oncologists say everyone with advanced cancer needs early palliative care. Here are 6 things to...
ABC News· 5 days agoPalliative care clinicians manage cancer-related symptoms and side effects from treatment, while...
Researchers provide a review and update on therapy of gastrointestinal tract tumors
Medical Xpress· 7 days agoGastrointestinal (GI) cancers, encompassing esophageal, gastric, small bowel, and colorectal...
NGS: the road to personalising cancer care
Medical Device Network via Yahoo Finance· 5 days ago“This is a powerful new technology,” Baehner says. “Today it's reimbursed in colorectal cancer, but I think this is a technology that will be broadly...
Three main signs of a tumor
Weston Forum· 6 days agoMore and more young people are getting colon cancer. Since sufferers do not immediately think of cancer when they experience their symptoms, it is often...
FDA Approves Adagrasib for KRAS G12C–Mutated CRC
Medscape· 4 days agoThis marks the first approval for a KRAS inhibitor to treat CRC.
RTP drugmaker plans 'headcount reductions' after failing late-stage trial - Triangle Business...
The Business Journals· 19 hours agoA biopharmaceutical company in Research Triangle Park has failed to hit its target in a pivotal,...
Study highlights importance of early detection in bile duct cancer for patients with rare liver...
Medical Xpress· 5 days agoPrimary sclerosing cholangitis (PSC) is a rare progressive liver disease that damages bile ducts and significantly increases the risk of bile duct cancer, particularly a type ...
GenFleet receives China NMPA approval for Phase I/II solid tumour trial
Clinical Trials Arena via Yahoo Finance· 5 days agoIn April, the US Food and Drug Administration granted approval for GenFleet to commence a Phase III...
